Expression of MDR-1/P-Glycoprotein in Childhood Acute Megakaryoblastic Leukemia Cells

References

• Endicott J. A., Ling V. The biochemistry of P-glyco-protein-mediated multidrug resistance. Annu. Rev. Biochem. 1989; 58: 137–171
   PubMed Web of Science ®Google Scholar
• Harber D. Multidrug resistance (MDR 1) in leukemia: Is it time to test?. Blood 1992; 79: 295–298
   PubMed Web of Science ®Google Scholar
• Arceci R. J. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood 1993; 81: 2215–2222
   PubMed Web of Science ®Google Scholar
• Yanovich S., Hall R. E., Gewirtz D. A. Characterization of a K562 multidrug-resistant cell line. Cancer Res. 1989; 49: 4499–4503
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Potentiation of vincristine and adriamycin effects on human hematopoietic tumor cell line by calcium antagonists and calmodulin inhibitors. Cancer Res. 1983; 43: 2267–2272
   PubMed Web of Science ®Google Scholar
• Yalowich J. C., Ross W. E. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro. Cancer Res. 1985; 45: 1651–1656
   PubMed Web of Science ®Google Scholar
• Tsuruo T., Iida H., Tsukagoshi Y. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation, with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982; 42: 4730–4733
   PubMed Web of Science ®Google Scholar
• Roninson I. B., Chin F. E., Choi K., Gros P., Housman D. E., Fojo A., Shen D., Gottesman M. M., Pastan I. Isolation of human mdr DN A sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA 1986; 83: 4538–4542
   PubMed Web of Science ®Google Scholar
• Choi K., Frommel T. O., Stern R. K., Perez C. F., Kriegler M., Tsuruo T., Roninson I. B. Multildrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cy-totoxic selection. Proc. Natl. Acad. Sci. USA. 1991; 88: 7386–7390
   PubMed Web of Science ®Google Scholar
• Chen C., Chin J. E., Ueda K., Clark D. P., Pastan I., Gottesman M. M., Roninson I. B. Internal duplication and homology with bacterial transport proteins in the mdr l (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–389
   PubMed Web of Science ®Google Scholar
• Nooter K., Oolstrum R., Jonker R., Van Dekken H., Stokdijk W., Van den Engh G. Effect of Cyclosporine A on daunorubicin accumulation in multidrug-resistant p388 leukemia cells measured by real-time flow cytometry. Cancer Chemother. Pharmacol. 1989; 23: 296–300
   PubMed Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Slamon D. L., Poplack D. G., Gottesman M. M., Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Fojo A. T., Shen D-W., Mickley L. A., Pastan I., Gottesman M. M. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug resistance gene. J. Clin. Oncol. 1987; 5: 1922–1927
   PubMed Web of Science ®Google Scholar
• Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I., Willingham M. C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 7735–7738
   PubMed Web of Science ®Google Scholar
• Noornan K. E., Beck C., Holzmayer T. A., Chin L. E., Wunder J. S., Andrulis I. L., Gazdar A. F., Willman C. L., Griffith B., von Hoff D. D., Roninson I. B. Quantitative analysis of MDR 1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 1990; 87: 7160–7164
   PubMed Web of Science ®Google Scholar
• Ito Y., Tanimoto M., Kumazawa T., Okumura M., Morishima Y., Ohno R., Saito H. Increased P-glycoprotein expression and multidrug-resistant genes (mdr1) amplification are frequently found in fresh acute leukemia cells. Cancer 1989; 63: 1534–1538
   PubMed Web of Science ®Google Scholar
• Rothenberg M. L., Mickley L. A., Cole D. E., Balis F. M., Tsuruo T., Poplack D. G., Fojo A. T. Expression of the mdr-I/P-170 gene in patients with acute lymphoblas, tic leukemia. Blood 1989; 74: 1388–1395
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y., Harada S., Furukawa T., Yoshimura A., Sumizawa T., Utsunomiya A., Ishibashi K., Saito Y., Uozumi K., Maruyama M., Ishizawa M., Arima T., Akiyama S. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990; 76: 2065–2071
   PubMed Web of Science ®Google Scholar
• Musto P., Melillo L., Lombardi G., Matera R., Di Giorgio G., Carotenuto M. High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br. J. Haematol. 1991; 77: 50–53
   PubMed Web of Science ®Google Scholar
• Shustick C., Groulx N, Gros P. Analysis of multidrug resistance (MDR-I) gene expression in chronic lymphocytic leukemia (CLL). Br. J. Haematol. 1991; 79: 50–56
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y., Yoshimura A., Harada S., Utsunomiya A., Makino T., Ishibashi K., Kodama M., Iwahashi M., Arima T., Akiyama S. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66: 868–873
   PubMed Web of Science ®Google Scholar
• Sato H., Preisler H., Day R., Raza A., Larson R., Browman G., Goldberg J., Vogler R., Grunwald H., Gottlieb A., Bennett J., Gottesman M., Pastan I. MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br. J. Haematol. 1990; 75: 340–345
   PubMed Web of Science ®Google Scholar
• Ball E. D., Malnar M., Ciminelli N., Mayer R., Wurster-Hill D., Davey F. R., Bloomfield C. D. Correlation of CD34 and multi-drug resistance P170 with FAB and cytogenetics but not prognosis in acute myeloid leukemia (AML). Thirty-Second Meeting of the American Society of Hematology, Boston, MA, 1990; 4, November 28-Decemberabstr 999
   Google Scholar
• Prirker R., Wallner J., Geissler K., Linkesch W., Haas O. A., Bettelheim P., Hopfner M., Scherrer R., Valent P., Havelec L., Ludwig H., Lechner K. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst. 1991; 83: 708–712
   PubMed Web of Science ®Google Scholar
• Marie J-P., Zittoun R., Sikic B. I. Multidrug resistance (mdr1) gene expression in adult acute leukemias: Correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586–592
   PubMed Web of Science ®Google Scholar
• Campos L., Guyotat D., Archimbaud E., Calmard-Oriol P., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression of acute nonlymphoblastic leukemia cells at diagnosis. Blood 1992; 79: 473–476
   PubMed Web of Science ®Google Scholar
• Goasguen E., Dossot J-M., Fardel O., Mee F. L., Leblay E. L., Gall R., Le Prise P. Y., Chaperon J., Fauchet R. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 1993; 81: 2394–2398
   PubMed Web of Science ®Google Scholar
• Boekhorst P. A. W., Leeuw K., Schoester M., Wittebol S., Nooter K., Hagemeijer A., Lowenberg B., Sonneveld P. Predominance of functional multidrug resistance (MDR-1) pheno-type inCD34+ acute myeloid leukemia cells. Blood 1993; 82: 3157–3162
   PubMed Web of Science ®Google Scholar
• Hart S. M., Ganeshaguru K., Lyttelton M. P. A., Prentice H. G., Hoffbrand A. V., Mehta A. B. Flow cytometric assessment of multidrug resistance (MDR) phenotype in acute myeloid leukaemia. Leuk. Lymph. 1993; 11: 239–248
   PubMed Web of Science ®Google Scholar
• Preisler H. Poor prognosis acute myelogenous leukemia. Leuk. Lymph. 1993; 9: 273–283
   PubMed Web of Science ®Google Scholar
• Lewi's D. S., Thompson M., Hudson E., Liberman M. M., Samson D. Down's syndrome and acute megakaryoblastic leukemia. Acta Haematol. 1983; 70: 236–242
   PubMed Web of Science ®Google Scholar
• Zipurski A., Peeters M., Poon A. Megakaryoblastic leukemia and Down's syndrome—A review. Progress. Clin. Biol. Res. 1987; 246: 33–56
   PubMedGoogle Scholar
• Cairney A. E. L., McKenna R., Arthur D. C., Nesbit M. E., Jr, Woods W. G. Acute megakaryoblastic leukemia in children. Br. J. Haematol. 1986; 63: 541–554
   PubMed Web of Science ®Google Scholar
• Ribeiro R. C., Oliveira M S. P., Fairclough D., Hurwitz C., Mirro J., Behm F. G., Head D., Silvia M. L. M., Raimondi S. C., Crist W. M., Krance R. Acute Megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. Leuk. Lymph. 1993; 10: 299–306
   PubMed Web of Science ®Google Scholar
• Perterson B. A., Levine E. G. Uncommon subtypes of acute nonlymphocytic leukemia: Clinical features and management of FAB M5, M6, and M7. Semin. Oncol. 1987; 14: 425–434
   PubMed Web of Science ®Google Scholar
• Sato T., Eguchi A., Fuse M., Hayashi Y., Ryo R., Adachi M., Kishimoto Y., Teramura M., Mizoguchi H., Shima Y., Komori I., Sunami S., Okimoto Y., Nakajima H. Establishment of a human leukaemic cell line (CMK) with megakaryosytic characteristics from Down's syndrome patient with acute megakaryoblastic leukaemia. Br. J. Haematol. 1989; 72: 184–190
   PubMed Web of Science ®Google Scholar
• Ishida Y., Ohtsu T., Hamada H., Sugimoto Y., Tobinai K., Minaro K., Tsuruo Y., Shimoyama M. multidrug-re-sistance in cultured human leukemia and lymphoma cell lines deiected by a monoclonal antibody, MRK16. Jpn. J. Cancer Res. 1989; 80: 1006–1013
   PubMedGoogle Scholar
• Sato T., Ota S., Kakuda H., Miura N., Niimi H., Ito M., Asai T., Tsuruo T., Fuse A. Expression of multidrug resistance gene (mdr-1/P-glycoprotein) in a megakaryoblastic cell line, CMK, and its enhancement with the megakaryocytic differentiation. Leuk. Lymph. 1994; 18: 515–520
   Web of Science ®Google Scholar
• Hamada H., Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 1986; 83: 7785–7789
   PubMed Web of Science ®Google Scholar
• Moriyama M., Kato T., Sato K., Sugawara I., Katsuta N., Hamada H., Tsuruo T., Hikage T., Kawamura Tomioka S., Ohoki T., Mitsuhashi S., Watanuki T., Tomioka S. Immunological diagnosis of multidrug resistant cancer in urological malignancies. Jpn. J. Cancer Chemother. 1990; 17: 502–508, Part-II(in Japanese)
   PubMedGoogle Scholar
• Chomozynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Sugimoto Y., Asami N., Tsuruo T. Expression of P-glycoprotein mRNA in human gastric tumors. Jpn. J. Cancer Res. 1989; 80: 993–999
   PubMedGoogle Scholar
• Murphy L. D., Herzog C. E., Rudick C. B., Fojo A. T., Bates S. E. Use of polymerase chain reaction in the quantitation of mdr-I gene expression. Biochemistry 1990; 29: 10351–10356
   PubMed Web of Science ®Google Scholar
• Pirker R., Goldstein L. J., Ludwig H., Linkesch W., Lechner C., Gottesman M. M., Pastan I. Expression of a multidrug resistance gene in blastic crisis of chronic myelogenous leukemia. Cancer Commun. 1989; 1: 141–144
   PubMedGoogle Scholar
• Chaudhary P. M., Roninson I. B. Expression and activity of P-glycoprotein, a multidrug eftlux pump, in human hematopoietic stem cells. Cell 1991; 66: 85–94
   PubMed Web of Science ®Google Scholar
• Avraham H., Vannier E., Cowley S., Jiang S., Chi S., Dinarello C. A., Zsebo K. M., Groopman J. E. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 1992; 79: 365–311
   PubMed Web of Science ®Google Scholar